Related Experiment Video

Updated: May 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stent restenosis and thrombosis: etiology, treatment, and outcomes

F van Buuren1, J B Dahm, D Horskotte

  • 1Department of Cardiology, Heart and Diabetes Center, North Rhine-Westphalia Ruhr University, Bochum, Germany. fvbuuren@hdz-nrw.de

Minerva Medica
|December 12, 2012
PubMed

Insights

Drug-eluting stents (DES) reduce restenosis and reintervention after coronary interventions. Newer biodegradable and polymer-free DES show promise for improved vessel function and reduced need for long-term antiplatelet therapy.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Drug-eluting stents (DES) significantly reduce restenosis and reintervention rates compared to bare metal stents (BMS) after percutaneous coronary intervention.
  • Despite benefits, long-term safety concerns, particularly stent thrombosis, necessitate careful evaluation.
  • Optimal stent implantation and antiplatelet therapy are crucial for successful outcomes.

Purpose of the Study:

  • To review the etiology, treatment, and outcomes of in-stent restenosis.
  • To provide an overview of new developments in stent technology, including biodegradable and polymer-free DES.

Main Methods:

  • Review of randomized controlled trials comparing DES and BMS.
  • Analysis of clinical presentations and management strategies for in-stent restenosis.
  • Evaluation of emerging stent technologies and their potential benefits.

Main Results:

  • DES consistently demonstrate significantly reduced reintervention rates compared to BMS.
  • Newer DES with biodegradable polymers, novel coatings, and polymer-free designs show promising early results.
  • Bioresorbable DES platforms offer potential for improved vessel function and reduced duration of dual antiplatelet therapy.

Conclusions:

  • DES represent a significant advancement in reducing restenosis after coronary interventions.
  • Emerging stent technologies, particularly bioresorbable DES, hold promise for enhanced patient outcomes and treatment paradigms.
  • Continued research is essential to fully elucidate the long-term safety and efficacy of novel stent platforms.

More Related Videos

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Reproducible Arterial Denudation Injury by Infrarenal Abdominal Aortic Clamping in a Murine Model08:33

Reproducible Arterial Denudation Injury by Infrarenal Abdominal Aortic Clamping in a Murine Model

Published on: November 24, 2016

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...